Chronic Kidney Disease Trial, Recruiting NCT07098351 Sponsor: Guangdong Provincial People's Hospital Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07098351
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 85 years old (any gender)
  • You have chronic kidney failure and have been receiving peritoneal dialysis regularly for at least 3 months, with no major changes to your treatment expected during the trial
  • You are able to understand the study, follow its procedures, and are willing to sign a consent form
  • During a baseline tracking period, you recorded your itching levels (using a scale) both morning and evening on at least 5 days, and your average itching score was high enough to meet the study's minimum threshold
  • During that same baseline period, your itching was rated as moderate or higher on at least 2 of those days (confirm with trial site)

Who may not be able to join:

  • You have not been following your dialysis treatment as required, in a way that could affect how the trial results are measured
  • Your peritoneal dialysis routine was changed within the 2 weeks before screening
  • You are currently on, or planning to start, hemodialysis within the next 2 months
  • You have a planned kidney transplant or non-emergency surgery scheduled during the study
  • You had a peritoneal infection (peritonitis) within the 4 weeks before screening that stopped you from continuing dialysis
  • Your liver function blood test results were significantly above the normal range during screening
  • Your itching is caused by something other than chronic kidney disease, such as an allergy, skin infection, or liver condition
  • You have serious heart disease, including severe heart failure, a recent heart attack, unstable chest pain, or dangerous heart rhythm problems
  • You have had an active cancer in the past 12 months, or have recently received cancer treatments such as chemotherapy, radiotherapy, or immunotherapy
  • You have an ongoing infection (such as active tuberculosis or HIV) that is not under control
  • Your blood pressure is very high and uncontrolled (top number 180 or above, or bottom number 110 or above)
  • You are currently taking steroid tablets or immunosuppressant medicines by mouth or injection (skin creams are generally acceptable)
  • You have a psychiatric condition or a cognitive (thinking/memory) disorder
  • You have recently started or changed certain medications that could affect itching or the study results — including antihistamines, certain steroids, nerve pain medications, or antidepressants — within 1–2 weeks before screening, or expect to change them during the study
  • You have used opioid-type pain medicines within the 2 weeks before screening
  • You have had light therapy (phototherapy) for itching within the past month
  • You have had a problem with drug or alcohol misuse within the past 12 months
  • You are allergic to opioids or to any ingredients in the trial medication
  • You have taken part in another clinical trial involving an experimental drug or device within the past 28 days
  • You are pregnant, breastfeeding, have a positive pregnancy test, or are unwilling to use contraception during the study
  • The trial doctor considers you unsuitable for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xueqing Yu, Guangdong Provincial People's Hospital

Phone: 8620-83827897

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
7 August 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Visual Analog Scale (VAS) score for Itch from baseline to Week4 of treatment period

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov